| Nome |
# |
|
Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature, file e27ce429-e44b-2581-e053-d805fe0acbaa
|
1.244
|
|
Acute renal infarction: a single center experience, file e27ce429-f651-2581-e053-d805fe0acbaa
|
695
|
|
Acute kidney injury associated with glomerular diseases, file e27ce42e-d0b3-2581-e053-d805fe0acbaa
|
517
|
|
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents, file e27ce42d-9fdb-2581-e053-d805fe0acbaa
|
274
|
|
Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein), file e27ce42d-a373-2581-e053-d805fe0acbaa
|
263
|
|
The dilemma of treating hepatitis C virus-associated cryoglobulinemia, file e27ce42e-f78d-2581-e053-d805fe0acbaa
|
254
|
|
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study, file e27ce42d-ae45-2581-e053-d805fe0acbaa
|
251
|
|
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome, file e27ce430-41be-2581-e053-d805fe0acbaa
|
189
|
|
IgG4-related kidney disease: The effects of a Rituximab-based immunosuppressive therapy, file e27ce42d-a4c4-2581-e053-d805fe0acbaa
|
118
|
|
Rituximab as a front-line therapy for adult-onset minimal change disease with nephrotic syndrome, file e27ce42d-ac56-2581-e053-d805fe0acbaa
|
117
|
|
Clinical exome sequencing is a powerful tool in the diagnostic flow of monogenic kidney diseases: an Italian experience, file e27ce432-5efb-2581-e053-d805fe0acbaa
|
114
|
|
The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study, file e27ce42d-eeb6-2581-e053-d805fe0acbaa
|
98
|
|
Daratumumab Monotherapy in Severe Patients with AL Amyloidosis and Biopsy-Proven Renal Involvement: A Real Life Experience, file e27ce430-e2fe-2581-e053-d805fe0acbaa
|
97
|
|
The challenge of treating hepatitis C virus-associated cryoglobulinemic vasculitis in the era of anti-CD20 monoclonal antibodies and direct antiviral agents, file e27ce42d-cded-2581-e053-d805fe0acbaa
|
95
|
|
CD38 and anti-CD38 monoclonal antibodies in AL amyloidosis: Targeting plasma cells and beyond, file e27ce42f-de50-2581-e053-d805fe0acbaa
|
95
|
|
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study, file e27ce42d-8fd3-2581-e053-d805fe0acbaa
|
85
|
|
Rituximab, cyclophosphamide, and corticosteroids for ANCA vasculitis: The good, the bad, and the ugly, file e27ce430-a500-2581-e053-d805fe0acbaa
|
84
|
|
A Prospective Study on Long-Term Clinical Outcomes of Patients With Lupus Nephritis Treated With an Intensified B-Cell Depletion Protocol Without Maintenance Therapy, file e27ce432-694b-2581-e053-d805fe0acbaa
|
60
|
|
Non HCV-Related Mixed Cryoglobulinemic Vasculitis With Biopsy-Proven Renal Involvement: The Effects of Rituximab, file e27ce435-723e-2581-e053-d805fe0acbaa
|
36
|
|
Renal Fibrosis in Lupus Nephritis, file 9828c83a-6f2f-455a-b6be-745d6b61e0bb
|
33
|
|
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation, file e27ce430-9b3b-2581-e053-d805fe0acbaa
|
30
|
|
New Onset Biopsy-Proven Nephropathies after COVID Vaccination, file e27ce435-3238-2581-e053-d805fe0acbaa
|
29
|
|
Treating Patients With ANCA-Associated Vasculitis and Very Severe Renal Injury With an Intensified B Cell Depletion Therapy: Comparison With a Control Cohort Receiving a Conventional Therapy, file e27ce435-3949-2581-e053-d805fe0acbaa
|
26
|
|
New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature, file e27ce429-f7e2-2581-e053-d805fe0acbaa
|
18
|
|
Moving toward personalized approaches in the management of lupus nephritis, file e27ce434-1d7a-2581-e053-d805fe0acbaa
|
13
|
|
Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen, file e27ce431-e06c-2581-e053-d805fe0acbaa
|
12
|
|
Long-term effects of intensive B cell depletion therapy in severe cases of IgG4-related disease with renal involvement, file e27ce431-e06e-2581-e053-d805fe0acbaa
|
12
|
|
The Challenging Management of Cancer: An Immunonephrologist's Perspective, file e27ce432-5e6f-2581-e053-d805fe0acbaa
|
12
|
|
Recognizing the new disorder "idiopathic hypocryoglobulinaemia" in patients with previously unidentified clinical conditions, file 73cdcf9e-20e1-4169-887a-02a6ac1fb4a5
|
8
|
|
The steroid-sparing effects of a mycophenolate mofetil-based regimen in the management of immunoglobulin A nephropathy in patients with histologically active lesions: A comparison with a control cohort receiving conventional therapy, file 07a93760-88b7-4017-b901-3996116d6c5e
|
6
|
|
Dickkopf Homolog 3 (DKK3) as a Prognostic Marker in Lupus Nephritis: A Prospective Monocentric Experience, file f2f69fe9-88f1-483b-bab2-50108e2ff0ba
|
6
|
|
Daratumumab monotherapy for refractory lupus nephritis, file 012fba5e-09fa-4702-97eb-176cd745d5c9
|
5
|
|
Chasing the Zebra: a case of membranous-like Glomerulopathy with SSA/RO52 deposits and no overt connective tissue disease, file 2a0a659a-1148-4220-8ace-f4283d88a1cf
|
5
|
|
Renal involvement as a unique manifestation of hemophagocytic syndrome, file 78f67454-24d4-46d6-acd4-ce946bc8bc73
|
5
|
|
Antiphospholipid syndrome and kidney involvement, file 8a10a64e-fd6b-4df8-995d-47486ab5e921
|
5
|
|
Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy, file a20e5b85-8dc7-4580-8975-d16ae53a1616
|
5
|
|
How the Availability of Anti-C5a Agents Could Change the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, file 83941324-7711-4dc4-b416-5ddda702b60f
|
4
|
|
Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature, file e27ce42d-e896-2581-e053-d805fe0acbaa
|
4
|
|
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19, file e27ce42f-fe97-2581-e053-d805fe0acbaa
|
4
|
|
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab, file 82d96280-fa92-4b83-9add-eaa99353f275
|
3
|
|
Acute renal infarction: a single center experience, file e27ce429-f8fd-2581-e053-d805fe0acbaa
|
3
|
|
ASIA Syndrome Following Breast Implant Placement, file e27ce42d-ac51-2581-e053-d805fe0acbaa
|
3
|
|
Outcome of patients with severe AL amyloidosis and biopsy-proven renal involvement ineligible for bone marrow transplantation, file e27ce430-9b3a-2581-e053-d805fe0acbaa
|
3
|
|
Cryoglobulinemic glomerulonephritis: Clinical presentation and histological features, diagnostic pitfalls and controversies in the management. State of the art and the experience on a large monocentric cohort treated with B cell depletion therapy, file e27ce433-3d48-2581-e053-d805fe0acbaa
|
3
|
|
L'importanza del laboratorio nella diagnosi e nella gestione della porpora trombotica trombocitopenica, file f3adbec1-25d6-417b-afd7-eda3bd823159
|
3
|
|
Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy, file 1f8481b0-3db1-416a-b6f4-ab8b24c6a1cb
|
2
|
|
The need for kidney biopsy in the management of side effects of target and immunotherapy, file 73144007-7c0b-46f8-9064-f65dfc25d490
|
2
|
|
Semi-selective plasma filtration applied to the treatment of acquired thrombotic thrombocytopenic purpura following bnt162b2 administration, file 754bfcdc-18aa-4ac2-9adf-a5d4af8ae34a
|
2
|
|
Relevance of next generation sequencing (NGS) data re-analysis in the diagnosis of monogenic diseases leading to organ failure, file bb50c7dd-6c49-4866-8b0d-b799478a2a8e
|
2
|
|
Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol, file bbc707de-c8d7-46d2-8baf-665234b527a0
|
2
|
|
New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature, file e27ce429-efa1-2581-e053-d805fe0acbaa
|
2
|
|
Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein), file e27ce42d-bb79-2581-e053-d805fe0acbaa
|
2
|
|
Anticoagulation in patients with concomitant lupus nephritis and thrombotic microangiopathy: A multicentre cohort study, file e27ce42d-c60e-2581-e053-d805fe0acbaa
|
2
|
|
High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study, file e27ce42d-e0bb-2581-e053-d805fe0acbaa
|
2
|
|
Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli’s regimen in membranous nephropathy, file e27ce42f-f52b-2581-e053-d805fe0acbaa
|
2
|
|
Anti-beta-2-glycoprotein I domain 1 identifies antiphospholipid antibodies-related injuries in patients with concomitant lupus nephritis, file e27ce430-d55b-2581-e053-d805fe0acbaa
|
2
|
|
Long-term, low-dose, intravenous vitamin C leads to plasma calcium oxalate supersaturation in hemodialysis patients, file e27ce434-41d9-2581-e053-d805fe0acbaa
|
2
|
|
Medullary sponge kidney, file e27ce434-5bb9-2581-e053-d805fe0acbaa
|
2
|
|
Assessing the steroid-sparing effect of biological agents in randomized controlled trials for lupus: a scoping review, file 70e5be66-0181-460d-8825-abec76c46fc6
|
1
|
|
Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents, file e27ce42d-bb7b-2581-e053-d805fe0acbaa
|
1
|
|
Rituximab in severe immunoglobulin-A vasculitis (Henoch-Schönlein) with aggressive nephritis, file e27ce42f-b0b4-2581-e053-d805fe0acbaa
|
1
|
|
Impact of pre-transplant antiaggregant and anticoagulant therapies on early hemorrhagic and cardiovascular events after kidney transplantation, file e27ce42f-b64f-2581-e053-d805fe0acbaa
|
1
|
|
Gadolinium-associated nephrogenic systemic fibrosis in patients with renal failure: the need for an interdisciplinary helping network, file e27ce434-5374-2581-e053-d805fe0acbaa
|
1
|
|
Nephrocalcinosis in Phosphate Nephropathy Following Oral Phosphate Purgative: A Role for Underlying Subclinical Primary Hyperparathyroidism?, file e27ce434-56ee-2581-e053-d805fe0acbaa
|
1
|
|
Is renal living-donor transplantation indicated in adult patients with orthotopic ileal neobladder? Lessons learned from a clinical case, file e27ce434-58fe-2581-e053-d805fe0acbaa
|
1
|
|
Structure-activity relationships of low molecular weight heparins expose to the risk of achieving inappropriate targets in patients with renal failure, file e27ce434-5bb7-2581-e053-d805fe0acbaa
|
1
|
|
The interactions of age, sex, body mass index, genetics, and steroid weight-based doses on tacrolimus dosing requirement after adult kidney transplantation, file e27ce434-61b5-2581-e053-d805fe0acbaa
|
1
|
|
Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: A single center experience, file e27ce434-664e-2581-e053-d805fe0acbaa
|
1
|
|
Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion, file e27ce434-743c-2581-e053-d805fe0acbaa
|
1
|
|
Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion, file e27ce434-743d-2581-e053-d805fe0acbaa
|
1
|
|
Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review, file e27ce434-743f-2581-e053-d805fe0acbaa
|
1
|
|
Decreased kidney function and crystal deposition in the tubules after kidney transplant, file e27ce434-a084-2581-e053-d805fe0acbaa
|
1
|
|
Renal Involvement in Transthyretin Amyloidosis: The Double Presentation of Transthyretin Amyloidosis Deposition Disease, file e27ce435-36d7-2581-e053-d805fe0acbaa
|
1
|
| Totale |
4.987 |